Go Pro

Bodycote plc (LON:BOY) Given Consensus Rating of "Moderate Buy" by Brokerages

Bodycote logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Bodycote has a “Moderate Buy” consensus rating from six analysts, split evenly between three buy ratings and three holds. The average 12-month price target is GBX 881.33.
  • Recent broker actions were generally positive: Deutsche Bank and Jefferies maintained buy ratings, while RBC and Berenberg raised their price targets to GBX 950 and GBX 933, respectively.
  • Bodycote shares opened at GBX 947.50, near their 12-month high of GBX 958, giving the company a market capitalization of approximately £1.60 billion. The company recently reported quarterly EPS of GBX 18.10.
  • Five stocks we like better than Bodycote.

Bodycote plc (LON:BOY - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six research firms that are presently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is GBX 881.33.

A number of research firms have issued reports on BOY. Royal Bank Of Canada increased their price target on Bodycote from GBX 750 to GBX 950 and gave the company a "sector perform" rating in a research report on Thursday, August 6th. Berenberg Bank upped their target price on shares of Bodycote from GBX 900 to GBX 933 and gave the stock a "hold" rating in a research note on Friday. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 960 target price on shares of Bodycote in a research note on Thursday, August 6th. Finally, Jefferies Financial Group reiterated a "buy" rating and issued a GBX 900 price target on shares of Bodycote in a research note on Wednesday, July 29th.

Get Our Latest Report on Bodycote

Bodycote Price Performance

Shares of LON BOY opened at GBX 947.50 on Tuesday. The stock has a market cap of £1.60 billion, a P/E ratio of 28.20, a PEG ratio of 1.44 and a beta of 1.35. The company has a current ratio of 1.12, a quick ratio of 0.74 and a debt-to-equity ratio of 35.03. Bodycote has a 12-month low of GBX 585 and a 12-month high of GBX 958. The business's fifty day simple moving average is GBX 796.98 and its 200-day simple moving average is GBX 739.62.

Bodycote (LON:BOY - Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported GBX 18.10 earnings per share (EPS) for the quarter. Bodycote had a return on equity of 9.30% and a net margin of 7.87%. As a group, equities analysts predict that Bodycote will post 54.0540541 EPS for the current fiscal year.

Bodycote Company Profile

(Get Free Report)

The leading provider of heat treatment and specialist thermal processing services worldwide. Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process. Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.

Further Reading

Analyst Recommendations for Bodycote (LON:BOY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bodycote Right Now?

Before you consider Bodycote, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bodycote wasn't on the list.

While Bodycote currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines